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Department of Vascular Surgery, G04.129, PO Box 85500, 3508 GA Utrecht, The NetherlandsGuidelines for the treatment of symptomatic carotid artery
disease currently recommend that carotid revascularization
should be performed as soon as possible and certainly
within 2 weeks of the index symptom. The underlying
reason for this is growing evidence that the highest risk
period for recurrent stroke is the early time period after
onset of symptoms, but this must be balanced against the
potential for incurring higher procedural risks. Accordingly,
in the current era of better medical therapy, the key
question is when exactly should interventions be performed
in order to prevent recurrent stroke while not unduly
increasing the procedural risk?
In this retrospective study, Strömberg et al.1 report on
the risk of recurrent stroke in a population being worked up
for carotid endarterectomy (CEA). The cohort consisted of
all patients who were referred for ultrasound imaging and
who were found to have a signiﬁcant ipsilateral carotid
artery stenosis. Clinical practice regarding the timing of CEA
evolved over time, as is demonstrated by a reduction in the
median delay from the “index symptom” to CEA of 36 days
in 2005, down to a median 7 days in 2011. The authors
concluded that with a 2% rate of recurrent stroke by day 2
(increasing to 4% by day 7), the risk of recurrent stroke was
much lower than had been described in earlier studies,
suggesting that there was maybe less need to perform
emergency carotid interventions than had been previously
thought.
However, the reader should be aware that these ﬁndings
only apply to a subgroup of patients undergoing CEA, as
those with “recurrent TIAs, stroke in evolution, or wors-
ening of symptoms” during the ﬁrst few days after referral
were excluded, because the authors were not convinced
that these patients would beneﬁt from acute surgery.
However, to this observer, any analyses of recurrent stroke
rates should include these “emergency cases”, otherwise
the reported ﬁndings may simply reﬂect outcomes in a
(biased) lower risk cohort. For example, if “stroke inDOI of original articles: http://dx.doi.org/10.1016/j.ejvs.2014.09.006,
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stroke at 48 hours increased from 2% to 3.2%.
The second key question relates to the risk of very early
revascularization. Strömberg et al.2 recommend against
performing CEA within the ﬁrst 48 hours, because of the
high risk of procedural stroke observed in an earlier national
audit. However, the current study did not assess procedural
risk and the methodology was insufﬁcient to draw any
conclusions regarding the risks of early surgery. However,
also included in the current issue of the Journal (and rele-
vant to this question) is a large series by Rantner et al.,3
who found no evidence that the procedural risk after CEA
increased signiﬁcantly in patients undergoing surgery within
48 hours of the most recent symptom.
In Stromberg’s current study, the authors based their
delay calculations on the time from the event that triggered
referral, but this was not necessarily the ﬁrst neurological
event. Although this is accepted practice, in terms of stroke
prevention, it is important to remember that the risk for
recurrent stroke is especially high in the ﬁrst few days after
the very ﬁrst event, that is, Stromberg’s data may still be
underestimating the actual risk of early recurrent stroke.
The exact deﬁnition of what is meant by the term “index
event” also has a large effect on the calculation of delay and
recurrent stroke rates,4 with delays being signiﬁcantly
longer following the ﬁrst event than following a subsequent
event that led to referral or even the most recent event.
The third question is which choice of intervention will
most beneﬁt the patient in the early time period after onset
of symptoms, and few studies have speciﬁcally reported on
outcomes of early carotid artery stenting (CAS). However, a
meta-analysis of all three European randomized trials
comparing CEA with CAS in symptomatic patients showed
that CEA was associated with a 3.2% procedural risk when
performed within 7 days of the index symptom, compared
with 9.3% when CAS was performed within 7 days of
symptom onset.5 Clearly, there is an urgent need for better-
quality data on the respective merits of intervening early to
prevent recurrent stroke versus the potential for increased
procedural risks. The ongoing Italian SPREAD-STACI trial
(which randomizes patients between urgent CEA within 48
hours versus delayed surgery between 48 hours and 14
days; www.staci.it) will provide important information to ﬁll
this gap in our knowledge.
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